Enago
Declaration

Guide to Authors

Manuscript submission

Manuscripts that do not adhere to the OA Publishing London guide to authors cannot be accepted. Submission to any OA Publishing London journal is exclusively online. The author will submit manuscripts using the online submission system. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail and via the author's page. Attention should be paid to the quality of the English usage, its grammar and spelling; this may necessitate review by an English speaker/language expert. Poorly written manuscripts will not be accepted.

 

Useful links

Example of submission letter to the journal's Editorial Team

What to include in the front page of your manuscript

Example of OAPL article

Example of letter of final agreement of the co-authors with OA Publishing London

Article processing charges for authors based in “high-income countries” institutes

Guide to Authors- OAPL

The OAPL appeals process

Standard submission of a manuscript through the online OAPL system

Submission of an invited manuscript through the online OAPL system

English copy-editing services for OAPL authors can be provided by Enago

 

OA Publishing London will accept the following types of manuscript:

 

Original research studies: Original research studies which have not been previously published, except in a preliminary form, may be submitted as original full-length research manuscript. Research manuscripts must adhere to contain comprehensive (structured) abstract, 5-10 keywords, and should ideally be between 3,500 - 6,000 words. The structure of the manuscript should include an abstract, introduction, materials & methods, results, statistical analysis, discussion and conclusion sections. These mainly include high-evidence prospective studies and randomised studies.


Research studies: Research studies, which have not been previously published, may be submitted as full-length research manuscript. Research manuscripts must adhere to contain comprehensive (structured) abstract, 5-10 keywords, and should ideally be between 3,500 - 5,000 words. The structure of the manuscript should include an abstract, introduction, materials & methods, results, statistical analysis, discussion and conclusion sections. These mainly include prospective studies and retrospective studies.


Systematic reviews: OAPL welcomes systematic reviews as they are regarded as the strongest form of medical evidence. Systematic reviews must adhere to contain comprehensive (structured) abstract, 5-10 keywords, and should ideally be between 3,500 - 6,000 words. The structure of the manuscript should include an abstract, introduction, materials & methods, results, statistical analysis and meta-analysis (if applicable), discussion and conclusion sections.


Case studies: Manuscripts in the form of case studies may be submitted. A case study should not include more than 2 tables and 3 figures and not exceed 2,000 words. The structure of the manuscript should include an abstract (structured), introduction, case study, results and discussion sections.


Case reports: Manuscripts in the form of short topical reports which are well illustrated are welcomed. They should contain text boxes and summaries to help rapidly convey the argument in question. They should be around 1,500 words. A case report should not include more than 1 table and 3 figures. The structure of the manuscript should include an abstract (structured), introduction, case report and discussion sections.


Case series: Manuscripts in the form of case series are welcomed. They should be around 2,500 words and should not include more than 2 table and 3 figures. Case series can be structured in two ways (1) abstract (structured), introduction, case series and discussion sections, (2) abstract (structured), introduction, materials and methods, results and discussion sections.


Editorials: Authors should contact the Editor-in-Chief with a concise outline of the proposed work prior to submission. Editorials are welcomed on any topic; however, they may also be related to work previously published in the relevant OA Publishing London hosted journal. Traditionally Editorials do not require an abstract but keywords aid article tracking. Editorials should be about 1500 words, with up to 10 references and no more than 2 well annotated tables and figures.  The relevant Editor-in-Chief of the particular journal can be contacted (e.g. Email address of OA Anatomy Editor-in-Chief: OA_Anatomy@oapublishinglondon.com).


Hypothesis: OA Publishing London welcomes submission of scientific hypotheses. Part of the submission should include testing of the scientific method. A hypothesis should not include more than 2 tables and 3 figures and not exceed 2,000 words. The structure of the manuscript should include (1) Structured abstract: Introduction, The Hypothesis, Evaluation of Hypothesis, Conclusion, (2) Structured manuscript: Introduction, The Hypothesis, Evaluation of Hypothesis, Empirical Data, Consequences of Hypothesis, Discussion, Conclusion. OA Medical Hypothesis is specialised in publishing Hypothesis articles.


Methodology: Unique scientific and clinical methodologies are always welcomed. The methodology section needs to be described in detail and the tools need to be scientifically proven. A methodology should not include more than 2 tables and 2 figures and not exceed 2,000 words. The structure of the manuscript should include an abstract (structured), introduction, methodology and discussion sections.


Short communications: Short communications from world authorities are always welcomed. The communication should aim to target one area of interest, highlighting problems and deficiencies and identifying solutions. A short communication should not include more than 1 table and 1 figure and not exceed 2,000 words. The structure of the manuscript should include an abstract (structured), introduction, short communication and discussion sections.


Study protocol: Publishing study protocols are of interest. The protocol needs to be structured and detailed. Clinical trials protocols are especially welcomed. A study protocol should not include more than 3 tables and 3 figures and not exceed 3,000 words. The structure of the manuscript should include an abstract (structured), introduction, study protocol and discussion sections.


Critical Reviews: These are by invitation only. This review will consist of approximately 2,500 words (not including references) and about 30 references. The structure of the manuscript should include an abstract (structured), introduction, materials and methods (if applicable), results (if applicable), discussion and conclusion sections. This review should be heavily illustrated and educational in nature. No article processing charges will be applied to this manuscript.


Reviews:  Topical reviews are welcomed. The aims of the review needs to be clearly defined and expects to have a high impact. A review should not include more than 3 tables and 3 figures and not exceed 4,000 words. The structure of the manuscript should include an abstract (structured), introduction, materials and methods (if applicable), results (if applicable), discussion and conclusion sections.


Letter-to-Editor: Letters to the editor relating to published work in the journal are welcomed. Letters should be closely related to the contents of the article they refer to. No other (unrelated) letters will be considered for publication.


Meeting reports: These are usually authorised overviews of specialist society meetings by a senior society council member outlining salient themes and detailing noteworthy research and should be about 3,500 to 5,000 words in  length and be heavily illustrated. Permissions from the researchers should be obtained.



 

Your duties as an ethical author is to always protect patients from harm and ensure scientific objectivity whether real or apparent through open disclosure. Other duties include:

To avoid copyright issues or duplicate publication and plagiarism

The author will only submit original work. The authors will not submit work subject to copyright. The author(s) by submitting a manuscript affirms that the work has not been published previously (except as an abstract/published lecture/thesis). The author(s) affirm that the work is not submitted for publication elsewhere. All author(s) must submit separate email addresses where confirmation of submission is sent and ensure that the manuscript has been approved by all authors and the organisation where the work was performed. If submitted work is published in a OA Publishing London Journal, the author(s) agrees not to publish the work elsewhere in the same form, in English or in any other language to prevent duplicate publication but may use the work or part thereof where this is not an issue.

Controlled studies

For any research project that prospectively allocates human participants to an intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome is considered a clinical trial (exemption for Phase 1 trials). Where practical within the resources available to the organisation, all randomised controlled studies submitted for publication in OA Publishing London should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart (http://www.consort-statement.org) and the trial registration number should be included in the manuscript abstract.

Protecting patient data

Patient information must be kept secure. Identifying data must not be used without expressed written informed consent (including the use of patient images or illustrations). Written consents must be provided to OA Publishing London on request. Even with such consent non-essential patient identifying data should be removed. Patients whose photographs are being taken, recording or of whom a report is being made and of all of the purposes for which you wish to use them and that individual (or responsible carer/parent in the case of children and vulnerable adults) must give their explicit written consent. If such consent is made subject to any conditions (e.g. prevent personal identification of the subject by digital means), OA Publishing London must be informed of these conditions. Extreme caution should be taken where children or vulnerable adults are concerned.

Other ethical considerations

Work on humans that are submitted to any OA Publishing London journals should conform to the values laid down in the Declaration of Helsinki (1964). The manuscript should contain a statement that the work has been approved by the relevant ethical committees related to the institution(s) in which it was performed and that subjects gave full informed consent to the work. The author will upload a copy of the ethics approval letter if applicable.

Studies involving experiments with animals must state that their care was in accordance with institution guidelines.

Declaration of competing and conflict of interests statement

All actual or potential conflicts of interests and competing interests should be stated.

By means of a "Conflict or Competing Interest Statement", all authors must disclose any financial and personal relationships with other people or organisations within the last 5 years of the beginning of the study that could potentially influence their work. Potential conflicts of interest include: employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts or competing interests, please state "none declared". This statement should be highlighted at the end of the discussion section of the submitted manuscript. OA Publishing London will use information as a basis for editorial decisions and may publish such disclosures if they are important to prevent confounding.

Declaration of funding source

Sources of funding should be declared within the manuscript as an acknowledgment at the end of the discussion section. The submission must outline in detail the role of the study sponsor(s), in the design; collection, analysis, and/or interpretation of data; in the writing of the manuscript; and in the decision for submission.

In addition the author(s) will not make libellous or defamatory statements.

The author will indicate whether they will accept consideration by another journal by the In-House Medical/Scientific Editors if their article is found not to be suitable for the primary journal.

 


Association for Medical Ethics

The Association for Medical Ethics (http://www.ethicaldoctor.org/) consists of physicians from every specialty of medicine. The purpose of the Association for Medical Ethics (AME) is to promote patient care and evidence-based medicine and to provide increased public awareness of the detrimental and pervasive financial influence of industry on many health care providers and patients. The Association for Medical Ethics promotes the care of patients absent of any consideration of financial gain or loss based on choice of surgical equipment, implant, manufacturer, hospital or surgery center. AME members practice informed consent and believe patients have a right to know if their doctor is a paid consultant or distributor for any manufacturer or product.

OA Publishing London and its journals will adhere to AME's Ethical Rules of Disclosure which are on the following URL: http://www.ethicaldoctor.org/ethical-rules-of-disclosure.

 


The International Committee of Medical Journal Editors

The International Committee of Medical Journal Editors (ICMJE) has produced and updated the "Uniform Requirements for Manuscripts (URM) Submitted to Biomedical Journals". The Medical Director and Senior Editor of Open Access Publishing London (OAPL) have agreed to incorporate the URM into the review and publication process of all OAPL journals. Download a PDF version of the full text of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals here.

 


The Council of Science Editors

The Council of Science Editors (CSE) has produced "Editorial Policy Statements" that cover the responsibilities and rights of editors of peer-reviewed journals. The Medical Director and Senior Editor of Open Access Publishing London (OAPL) have agreed to incorporate these Statements into the review and publication process of all OAPL journals.

 


OAPL self-archiving policy

Authors may archive pre-print and post-print versions of their articles for the purpose of self-archiving or deposit.

Authors may use OAPL's version (final PDF) for the purpose of self-archiving or deposit. The link must be accompanied by the following text: “The final HTML/PDF is also available at http://www.oapublishinglondon.com/”.

 


Detailed Guide to Authors

OA Publishing London will consider manuscripts prepared to the standards outlined by the International Committee of Medical Journal Editors ("uniform requirements for manuscripts submitted to biomedical journals", http://www.icmje.org). Authors are advised to read these guidelines.

Manuscripts should be submitted with a structured stand-alone abstract:  title, introduction, materials and methods, results, discussion and key words. The abstract should state the purpose of the research, brief methodology and the essential results and main discussion. Abstracts should not exceed 300 words.

Authors should remember that the readership may not be conversant in the author's particular field and writing should reflect this and be aimed for a very educated scientifically/medically based readership

The body of a standard original research study manuscript (for example) should contain:

Title

Titles are indexing and citation system; so should be relevant, concise and designed to ensure interest and download. Do not use abbreviations.

Authorship

Author names and affiliations: last name and initials (e.g. Smith JK) and affiliations should be written. No change in authorship will be possible within a particular submission cycle.

Corresponding author(s): precisely indicate which author(s) will deal with any correspondence during all stages of refereeing and publication in a timely fashion. Make certain that current e-mail address, complete postal address and telephone number (with country and area code) are provided. Skype name and country may also be given.

Keywords

Should be placed after the abstract. Provide a maximum of ten keywords, to be chosen from the Medical Subject Headings from Index Medicus. These keywords will be used for indexing purposes.

Abbreviations

Define abbreviations or acronyms that are not standard in the field at their first occurrence in the article. Ensure consistent usage of abbreviations throughout the manuscript. Abbreviations should not be used in the abstract.

 

An Introduction: detailing background, precedents and logical argument. What the present study adds to literature and the main aims of the study.

Materials and methods: patients inclusion/exclusion and technical details of materials should be provided. If applicable, should include a statement that all work must be conducted in accordance with the Declaration of Helsinki (1964); a statement should also be included regarding ethical approval and consenting process (human studies) and a statement regarding the Humane Treatment of laboratory Animals (if applicable). There should be sufficient detail to enable accurate repetition by another group.

Statistical analysis: all statistical methodologies should be clearly outlined and the rationale for their use explained.

Results: these should be presented in an accessible form (tables, simple figures, summary text boxes and numerous illustrations) and thoroughly explained as well as the effect of potential confounding. It should be noted that successful manuscripts are very well illustrated with comprehensive legends.

Discussion: this should discuss the current work in the perspective of the literature; the implications of the research should be expounded.

Tables: easily interpreted academic tables are recommended. Tables should not be embedded in the manuscripts but uploaded separately. The legends of the tables should be embedded in the manuscript after the “references” section.

Figures: should be sent as high quality TIFF files. Figures should not be embedded in the manuscripts but uploaded separately. The legends of the figures should be embedded in the manuscript after the “tables” section.

References: liability for the accuracy of citations lies exclusively with the authors. The author will cite all references only in Vancouver style as adapted by (1) National Library of Medicine in the U.S.

1. Patrias K. Citing medicine: the NLM style guide for authors, editors, and publishers [Internet]. 2nd ed. Wendling DL, technical editor. Bethesda (MD): National Library of Medicine (US); 2007 [updated 2009 Oct 21; cited 2010 March 7]. Available from: http://www.nlm.nih.gov/citingmedicine.

References should be numbered consecutively in order of appearance in the body of the manuscript – they are identified by Arabic numerals and as superscripts, e.g. Good et al.1

Standard journal articles

1.         Good R, Efernces M, Ean S, Uces S . Cancer cures: the fiction and facts. OA Biotechnology. 2012 Apr;1(4):489-98.

Articles not in English

2.         Good R, Efernces M, Ean S, Uces S . Lutte contre le cancer : une fiction et les faits. OA Cancer. 2012;1:178-91. French.

Books: Personal author(s)

3.         Good R, Efernces M, Ean S, Uces S . Cancer. 1st ed. London: OA Publishing London; 2012.p14-15.

Books: Editor(s) as authors

4.         Good R, Efernces M, Ean S, Uces S, editors. The manual of statistical inferences. 1st ed. London: OA Publishing London; 2012.p1-14.

Books: Authored chapter in edited publication

5.         Good R, Efernces M, Ean S, Uces S . Duplicate publication makes everyone look bad. In: Good R, Efernces M, editors. Cancer managment1st ed. London: OA Publishing London; 2012.p16-20.

Electronic material

6.         OA Publishing London [homepage on the Internet]. London: OA In-House Editorial Department; 2012 [updated 01 Jan 2012; cited 30 May 2012]. Available from: http://www.oapublishinglondon.com.

Legends (to Figures and Tables)

Very detailed legends must be supplied numbered in the order of appearance in the manuscript after the references section.

Detailed Preparation of Figures

Ensure uniform lettering (size and Arial font). All figures must be numbered according to their occurrence in the text. Corresponding file names must be given to figure files. Correspondingly numbered detailed figure legends must be provided separately at the end of the text after the references section.

Formats

Please do not use: embedded graphics; low resolution image formats (JPEG, GIF, BMP, PICT, WPG) and poorly scaled illustrations.

Finalised e-illustrations should be "saved as" or converted in a TIFF format. TIFF: photographs (halftones): ≥300 dpi. TIFF: Bitmapped vector graphic line drawings: ≥1000 dpi. TIFF: Blended bitmapped line/half-tone ≥500 dpi.

Tables

Detailed legends to the tables must be given in the legends section after the references section. Do not duplicate results described elsewhere in the manuscript.

Footnotes

We do not accept footnotes.

Line drawings

The lettering and symbols, as well as other details, should have proportionate vector dimensions, and should be capable of adaptive scaling. The degree of reduction will be determined by the publisher. Figures will not be enlarged. Avoid any form of shading.

Photographs

Remove non-essential areas of a photograph. Do not mount photographs unless they form part of a composite figure. Insert a scale bar in the illustration (as appropriate).

Additional data

At the present time, OA Publishing London do not accept supplementary e-material.

Copyright

The submitting authors to OA Publishing London are liable for any copyright infringement for all their submitted work. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. OA Publishing London has prepared forms for use by authors; please contact us: Office@oapublishinglondon.com

OA Publishing London authors retain the copyright to their work. When the authors retain the copyrights to their work, they are allowed unlimited use and/or distribution of their work without any form of restriction. In this model, articles are freely downloadable from OA Publishing London website, OA Publishing London journals’ websites or any website supported by OA Publishing London. In this model, articles and data can be re-used and re-distributed without restrictions, as long as the original work of the author(s) is clearly and correctly identified and cited.

Proposals for manuscript reviewers

You may provide the names of potential reviewers for your manuscript. Do not recommend reviewers from your organisation or previous or current associates. Give full names, addresses and email addresses of suggested reviewers. The final choice of reviewers is that of the Handling Editor and the journal reserves the right not to use reviewers which have been suggested.

Proofs

Proofs are not to be regarded as "drafts". The submission of the manuscript to the publisher regarded as final.  Page proofs in PDF format will be sent to the corresponding author's supplied e-mail, to be checked for typesetting/editing.  No material changes in the accepted manuscript will be allowed. Proofreading is exclusively the author(s) liability. It is important to ensure that all manuscript corrections are sent at a single communication. Subsequent corrections are inadmissible.

 


Nomenclature and style

Amino acids
The full residue names or the three-letter symbols are preferred to the one-letter symbols in the text. Either system may be used in sequences.

Animals
The full binominal Latin names needs to be included for all experimental animals other than common laboratory animals. The strain of laboratory animals should be clearly stated.

Array data
OA Publishing London recommends that authors adhere to the MIAME guidelines for the submission of gene chip array data (see http://www.mged.org/Workgroups/MIAME/miame.html).

Biochemical nomenclature
OA Publishing London recommends that authors follow the recommendations of the Nomenclature Committee of IUBMB and the IUPAC–IUBMB Joint Commission on Biochemical Nomenclature (see http://www.chem.qmul.ac.uk/iubmb/).

Centrifugation
When conditions for centrifuging are critical, sufficient information should be given for the procedure to be repeated. The centrifugal field should be stated, based on the average radius of rotation of the liquid. The quantitative composition of the suspension medium should be stated. The centrifuge rotor should be unambiguously identified and the temperature of operation stated. The time of operation of the rotor at sustained plateau speed should be stated.

Chemical nomenclature
OA Publishing London recommends that authors follow the IUPAC recommendations on chemical nomenclature (see http://www.chem.qmul.ac.uk/iupac/index.html). Chemical symbols may be used for elements, groups and simple compounds, but authors are advised that the excessive use of chemical symbols may reduce the readability of a paper.

Chromatography
The rate of movement of a substance relative to the solvent front in paper or thin-layer chromatography is best expressed as its RF value, or, if relative to a reference compound, by its Rcompound value.

Computer programs
If the use of a computer program forms a significant and essential part of the work described in the manuscript, the program must be adequately documented.

Electrophoresis
Electrophoretic mobilities (m) and the composition of the electrophoretic medium, pH and temperature should be quoted. The operative voltage should be specified where possible. The symbol pI should be used for isoelectric point.

Enzymes
The recommendations of the latest edition of Enzyme Nomenclature (1992, ISBN 0 12 227 165 3, Academic Press, San Diego; and its supplements) should be followed as far as possible (see http://www.chem.qmul.ac.uk/iubmb/enzyme).

Gene nomenclature and symbols
OA Publishing London recommends that authors use the symbols and nomenclature recommended by the HUGO Gene Nomenclature Committee which is responsible for approving and implementing unique human gene symbols and names, and works closely with the Mouse Genome Database and other organism databases. Considerable efforts are made to approve symbols acceptable to workers in the field, but sometimes it is not possible to use exactly what has previously appeared in the literature. In such cases the previously used symbols are listed as aliases for the approved nomenclature in the Human Genome Nomenclature Database (http://www.genenames.org/) and Entrez Gene (http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene) to allow retrieval of all the information available for each gene.

Isotopes
Where possible radioactivity should be expressed in absolute terms; the SI unit for radioactivity is the becquerel (symbol Bq), defined as 1 disintegration/s, but the curie (symbol Ci; 1 Ci = 3.7×1010 Bq) may also be used. Alternatively, radioactivity may be expressed as disintegrations (or counts) per unit of time.

Mathematical modelling papers
OA Publishing London welcomes modelling papers where they advance our knowledge of biochemistry and cellular and molecular biology.

Micro-organisms
In the title, in the synopsis and at the first mention in the text, micro-organisms must be given their full binominal Latin name, which will be printed in italics. Each organism should preferably have been obtained from or deposited with a recognized collection of micro-organisms, and the collection number must be given. Alternatively, a strain number or name should be quoted; this should not be italicized.

Molecular mass and the dalton
There are two preferred ways of specifying the mass of a biochemical entity. 'Relative molecular mass' is the ratio of the mass of a molecule to of the mass of the nuclide 12C; it is thus dimensionless. 'Molecular mass' is the mass of one molecule of a substance expressed in daltons (symbol Da) or atomic mass units; the dalton is defined as of the mass of one atom of 12C.

Nucleotide and protein sequences
Authors should note that nucleotide sequences should be fully determined on both strands of the DNA. An explicit statement to this effect and a supporting diagram summarizing the sequence data are normally sufficient evidence.

Pharmacological inhibitors
For studies employing cell-permeable chemical inhibitors to address protein function in cellular regulation, it is recommended that submitting authors consult the guidelines provided in Table 1 in the following review, which sets out useful criteria that should be met before any investigation using such compounds may be accepted for publication: Cohen, P. (2010) Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem. J. 425, 53-54.

Physical quantities and units
The recommended SI symbols should be used for all physical quantities and units (see Quantities, Units and Symbols in Physical Chemistry, 3rd edn., 2007, RSC Publishing, Cambridge, U.K.). A list of the most commonly used quantities and units appears in Table 2. Where a quantity is given in terms of non-SI units, the SI equivalent should generally also be stated. However, distance measurements at the molecular scale may be given in terms of the ångström (Å) only.

Plants
The full binominal Latin names should be included for all plant species. Where appropriate, the variety and the source should be specified.

Prefixes for multiples and submultiples of units
These should be as follows:


Multiple Prefix Symbol Multiple Prefix Symbol
1012      tera       T        10-2      centi      c*
109        giga      G        10-3      milli       m
106        mega    M       10-6      micro     µ
103        kilo        k        10-9      nano      n
102        hecto    h*       10-12    pico       p
10          deka     da*     10-15    femto     f
10-1       deci      d*       10-18    atto       a
* To be avoided where possible (except for cm).

 

Promoter mapping studies
Simple promoter mapping studies are not acceptable unless they show novel and significant cis-acting elements and the factors they bind, and these extend our knowledge of the function of the gene in question.

Policy on making reagents available
If, in their paper, authors describe new chemicals or propagatable biological materials (including cell lines, DNA clones and antibodies), they are strongly encouraged to make these available to academic workers who request them for non-commercial research projects. Authors are urged to deposit cell lines of more than local interest with appropriate collections at national centres.

RNA interference
Papers reporting data acquired by the use of RNAi (RNA interference) must demonstrate appropriate controls [see Nature Cell Biol. (2003), 5, 489-490].

Solutions
Solutions should be described in terms of molarity (M); 'normality' (N) is not acceptable. Fractional concentrations should be expressed in the decimal system, For aqueous solutions of concentration less than 1%, w/v need not be inserted if it is clear that the concentration is stated in terms of weight of solute. Incubation media such as Krebs–Ringer solution, Eagle's medium, Waymouth's medium etc. should be defined by reference.

Sources of materials
The commercial sources of chemicals and reagents should be stated, but company addresses need not be given.

Spectra and spectroscopic data
Full spectra should be published when important or novel features are demonstrated. The spectra for UV and visible absorption, fluorescence, circular dichroism and optical rotation should have a wave-length scale whether or not a wavenumber scale is given. Where possible, molar terms should be used in absorption, circular dichroism and optical rotation.

Statistical treatment of results
Data from a sufficient number of independent experiments should be reported to permit evaluation of the reproducibility and significance of the results. When the object is to determine the value of a quantity or the statistical characteristics of a population, sufficient information is usually conveyed by the following: (i) the number of independent experiments (replicate measurements in an individual animal or preparation and results from pooled tissues etc. represent only one independent estimate); (ii) the mean value; (iii) the standard error of the estimate of mean value (S.E.M.), the standard deviation (S.D.) or the coefficient of variation, as may be appropriate. In analysing the statistical significance of differences between data sets, it should be made clear which statistical tests have been applied and the choice of statistical test should be appropriate to the analysis.

Structural data
For papers describing structures of biological macromolecules, the atomic coordinates and the related experimental data (structure factor amplitudes/intensities and/or NMR restraints) must be deposited at a member site of the Worldwide Protein Data Bank (www.wwpdb.org): RCSB PDB (www.pdb.org), PDBe (www.ebi.ac.uk/pdbe), PDBj (www.pdbj.org) or BMRB (www.bmrb.wisc.edu). The PDB ID should be included in the manuscript.

Trademarks
Registered trademarks should be identified by the symbol ® where they appear in the text.

 


Author Enquiries

OA Publishing London Office: Office@oapublishinglondon.com

Publishing Director: Publishing_Director@oapublishinglondon.com

Medical Director: Medical@oapublishinglondon.com

Senior Editor: Editor@oapublishinglondon.com

 


General Information

Manuscripts will be submitted as a Microsoft Word (DOCX) in 12 pt Arial. Please write your manuscript in high quality English (UK).

The text should be in single-column format with simple text layout as formatting codes will be removed and replaced on processing the article. We commend bold face, italics, subscripts, superscripts…etc. When preparing tables and when employing a table grid, allow only one grid for each individual table. If no grid system is used, then employ use tabs delimits only to align columns (do not use spaces). To avoid embarrassment use the "spellchecker" function. Avoid justifying text or hyphenating words. Avoid embedding "graphically designed" equations or tables.  Avoid importing figures into the text file, instead do indicate their approximate locations directly in the manuscript.

 

Language Editing Services

All OAP London submissions and editorial correspondence must be in English. Appropriate use of English language is required for review and publication in OAP London journals. Use of professional editing services, where assistance is provided with basic writing and construction of the manuscript, is sometimes considered by authors, especially if English is not their primary language. Professional editing assistance greatly helps communicate your ideas to fellow scientists, editors and reviewers.

OAP London is pleased to collaborate with Enago, one of the world’s leading English Language editing service provider, for our authors. Enago has been selected specifically for their English as a second language capabilities and years of experience with scientific manuscripts. Authors for whom English is not the primary language can use Enago’s language editing services to improve grammar, syntax, and flow of their manuscripts prior to submission to the OAP London journals.

Enago offers localized websites in Japanese, Korean, Russian, Simplified Chinese, Portuguese, Traditional Chinese, Turkish, German, Brazilian, Persian and Arabic. Local payments and invoices are also offered for your convenience.

Authors understand that the English editing services offered are completely independent of OAP London and the peer review process. Also, authors are responsible for all payments to Enago when using Enago’s services.

Read more on language editing services

Read about OAPL-Enago Declaration

 


Quick Submission checklist

It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor-in-Chief for review. Ensure that the following items are present:

Other checks:

 

 


ABOUT SSL CERTIFICATES